biology

Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020

Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 is a biology topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 rather than just read about it. In short: The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (SI 2020/1125) is a statutory instrument (SI) that was laid before Parliament on 16 October 2020 to make provision for the strengthening of existing regulations that allow for the temporary authorisation of the supply of unlicensed medicines, including vaccines, in response to certain public health threats, and for the expansion of the work…

Key takeaways

Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 belongs to biology; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 from memory before moving on to harder problems.

Reference excerpt

The Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 (SI 2020/1125) is a statutory instrument (SI) that was laid before Parliament on 16 October 2020 to make provision for the strengthening of existing regulations that allow for the temporary authorisation of the supply of unlicensed medicines, including vaccines, in response to certain public health threats, and for the expansion of the workforce able to administer the COVID-19 vaccines and influenza vaccines. Certain amendments within the instrument, regulations 3, 12 and 3, allowing for the administration of vaccines by a wider range of medically trained people such as an "occupational health vaccinator" are time-limited to 1 April 2022. The statutory instrument also makes provision for temporary authorisations where the existing partial immunity (for registered healthcare professionals) from civil liability is extended to pharmaceutical companies in relation to temporarily authorised medicinal products.

Regulation 174A A new regulation (174A) has been added to Regulation 174 of the Human Medicines Regulations 2012 which will provide temporary authorisation for the promotion of medicinal products, including COVID-19 vaccines, in limited forms of advertisements where permitted in campaigns "relating to the suspected or confirmed spread of pathogenic agents". The existing regulations under the Human Medicines Regulations 2012 for the disapplication of certain advertising restrictions for unlicensed vaccines are expanded by these regulations to permit temporary authorisation of any medicinal products for the purposes of any campaign approved by ministers.

Temporary authorisation of vaccine BNT162b2 On 2 December 2020, a temporary authorisation was issued under Regulation 174 of the Human Medicines Regulations 2012 (as amended by Regulation 174A) for the implementation of the first COVID-19 vaccine, the Pfizer/BioNTech (BNT162b2), to be used in the United Kingdom. The authorisation was subject to a number of conditions which fall under Regulation 174A(1) of these amending regulations. The temporary authorisation meant that a new COVID-19 vaccine could be approved by the MHRA without having to wait for the usual approval of the European Medicines Agency.

See also COVID-19 vaccination programme in the United Kingdom MHRA - Notable Interventions

References

External links Official website

Illustrations

Worked examples

Example 1 — a first encounter with Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020

Start with the simplest possible case. Write down what Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In biology, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020

In research: Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 appears in biology research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 is common in secondary-school and first-year university syllabi. It links to neighbouring topics 2020 in British law, 2020 in England, COVID-19 pandemic in England, so understanding it makes those chapters shorter.
In everyday life: Look for Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 in simple terms?

Why does Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020 matter?

Because it connects several biology ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Human Medicines (Coronavirus and Influenza) (Amendment) Regulations 2020.